Liver metastatic load >50%, Ki-67 >10% and bone metastasis were independent prognostic factors for PFS; while TAE was more efficacious in patients with Ki-67 ≤10%, no bone metastasis, and well-defined liver metastatic tumor (78). Here, MKI67 is linked to bone metastasis.